How much revenue does Fuso Pharmaceutical Industries,Ltd. make?

Fuso Pharmaceutical Industries,Ltd. reported 60.56 billion JPY in revenue for fiscal year 2025, up 9.3% from 55.41 billion JPY in fiscal year 2024.

What companies are similar to Fuso Pharmaceutical Industries,Ltd.?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Hoya Corporation (7741.T), Menicon Co., Ltd. (7780.T), Seed Co.,Ltd. (7743.T), Renascience Inc. (4889.T).

Fuso Pharmaceutical Industries,Ltd. (4538.T) Stock

About Fuso Pharmaceutical Industries,Ltd.

Fuso Pharmaceutical Industries,Ltd. engages in the manufacture and sale of pharmaceuticals and medical equipment in Japan. The company offers injectable drugs and dialysis agents for artificial kidneys, as well as medical drugs and equipment. It also engages in the contract manufacturing of drugs; and real estate leasing businesses. The company was incorporated in 1937 and is based in Osaka, Japan...

At a glance

Fuso Pharmaceutical Industries,Ltd. reported revenue of 60.56 billion JPY for fiscal year 2025, up 9.3% from fiscal year 2024, and net income of -3.29 billion JPY.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.